Carole Nuechterlein, Director of Aligos Therapeutics ALGS, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/25.

CN

CN

Carole Nuechterlein

Director

Company

Aligos Therapeutics ALGS

First filing

23/07/21

Trades

8 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aligos TherapeuticsALGS	Open-market buy	23/10/25	23/10/27	7,933,601 sh	$0.76	$6,029,536.76	+256.6%